Fulcrum Therapeutics Statistics
NASDAQ: FULCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.67-0.02 (-0.54%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Fulcrum Therapeutics by the numbers
Fulcrum Therapeutics has a market capitalization of $280.0 million based on 76.30M shares outstanding. With trailing EPS of $-1.21, Fulcrum Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.9% below its 50-day average and 43.8% below its 200-day average.
Average daily trading volume is 1.56M shares, or about $5.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
FULC valuation vs. peer median
| Metric | FULC | Peer median | Difference |
|---|---|---|---|
| Market cap | $280.01M | $283.25M | -1% |
| Avg. volume | 1.56M | 1.15M | +35% |
Peer median across 8 companies: CATX, RCKT, LRMR, BBOT, BIOA, VNDA, ABEO, INDP.
Valuation
- Market cap
- $280.01M
- EPS (TTM)
- $-1.21
- Shares outstanding
- 76.30M
Price and trading
- Previous close
- 3.69
- Open
- 3.70
- Day range
- 3.67 – 3.72
- 52-week range
- 2.83 – 15.74
- 52-week change
- -60.28%
- Beta
- —
- Volume
- 1.04M
- Average volume
- 1.56M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 280.01M
- Forward Pe
- -6.70
- Eps
- -1.21
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 15.74
- Week52 Low
- 2.83
- Avg Volume
- 1.56M
- Shares Outstanding
- 76.30M
- Ma50
- 3.78
- Ma200
- 6.53
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -76.68%
- Pct From52w Low
- 29.68%